Patent Assignment
Reel/Frame 028921/0475
Notice of Change in Registered Office Address
Recorded: 2012-09-07
Pages: 2
Assignor
EDT PHARMA HOLDINGS
Executed: 2011-08-15
Assignee
EDT PHARMA HOLDINGS
MONKSLAND, ATHLONE, CO. WESTMEATH, IRELAND
Covered Properties
(4)
Injectable Nanoparticulate Olanzapine Formulations
Nanoparticulate Corticosteroid and Antihistamine Formulations Methods of Making, and Methods of Administering Thereof
Injectable Nanoparticulate Olanzapine Formulations
Application:
12/333,233 →
Publication:
US 2009/0155331
Injectable Nanoparticulate Olanzapine Formulations
Application:
13/024,315 →
Publication:
US 2011/0195095
Related Assignments
(11)
Other recorded transfers of the patents in this record — the chain of ownership.
Notice of Change of Address
Jul 5, 2011
From: ELAN PHARMA INTERNATIONAL LIMITED
To: ELAN PHARMA INTERNATIONAL LIMITED
Reel/Frame 026544/0598 →
Patent Security Agreement (Second Lien)
Sep 29, 2011
From: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 026994/0245 →
Patent Security Agreement (First Lien)
Sep 29, 2011
From: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 026994/0186 →
Notice of Change in Registered Office Address
Sep 7, 2012
From: ALKERMES PHARMA IRELAND LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 028921/0519 →
Asset Transfer Agreement
Sep 7, 2012
From: ELAN PHARMA INTERNATIONAL LIMITED
To: EDT PHARMA HOLDINGS LIMITED
Reel/Frame 028921/0442 →
Change of Name
Sep 7, 2012
From: EDT PHARMA HOLDINGS LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 028923/0247 →
Release by Secured Party (Second Lien)
Oct 12, 2012
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
Reel/Frame 029116/0379 →
Release of Patent Security Agreement (First Lien)
Dec 24, 2024
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 069771/0548 →
Security Interest
Oct 23, 2025
From: ALKERMES PHARMA IRELAND LIMITED
To: JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT
Reel/Frame 073213/0302 →
Release of Security Interest in Patents Previously Recorded at Reel/Frame (073213/0302)
Feb 13, 2026
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 074858/0429 →
Security Interest
Feb 13, 2026
From: ALKERMES PHARMA IRELAND LIMITED
To: JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT
Reel/Frame 074858/0405 →